BioPlus Acquisition Corp - Class A
BIOS
Get informed when a big investor buys or sells
+ FollowMarket Cap$209.07M
Close$
$10.80
0% upside
Current Fair Value
0% upsideOvervalued by 0% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $209.07 Million |
|---|---|
| Enterprise Value | $214.32 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.01 |
| Beta | 0 |
| Outstanding Shares | 24,482,000 |
Return
| Return on Equity | 9.72% |
|---|---|
| Return on Assets | 8.55% |
| Return on Invested Capital | -0.78% |
Valuation & Multiples
| P/E Ratio | 1249.89 |
|---|---|
| PEG | 399.33 |
| Price to Sales | - |
| Price to Book Ratio | 2.7 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -200.48 |
| Enterprise Value to Net Income | 18 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data